Kriti Nutrients financials

·FMCG & RetailChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹247cr+7.9% on Q1 FY26
Net profit
₹8.9cr−6.0% on Q1 FY26
EBITDA margin
4.8%−0.2 pts on Q1 FY26
EPS
₹1.78−5.8% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue247229+7.9%
EBITDA11.811.4+3.9%
EBITDA margin4.8%5.0%−0.2 pts
Profit before tax11.711.9−1.2%
Net profit8.99.5−6.0%
EPS₹1.78₹1.89−5.8%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹247 crNet profit₹8.9 crNet margin3.6%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
321————
49.349.313.89.319.0
7.67.62.810.0—
279————
940922734——
—+25.5%———
43.943.448.0——
4.7%4.7%6.5%——
38.037.742.6——
33.333.937.0——
3.5%3.7%5.0%——
₹6.65₹6.77₹7.38——
—−8.4%———
—64.332.049.819.9
—−5.6−4.6——
58.758.727.349.819.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

KRITINUT₹64.02

Kriti Nutrients Limited

· FMCG & Retail
₹ CrorePeersGOKULHALDERMKPLROMLNKINDSUNDROPMcap ₹321 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————320.8
- Cash, Equiv & ST Investments19.09.313.849.349.3
+ Total Debt—10.02.87.67.6
Enterprise Value————279.0
Revenue——734.3921.5939.6
Growth %, YoY———+25.5—
EBITDA——48.043.443.9
Margin %——6.544.714.67
EBIT——42.637.738.0
Net Income——37.033.933.3
Margin %——5.043.683.55
EPS, Adj (current shares)——7.386.776.65
Growth %, YoY———-8.4—
Cash from Operations19.949.832.064.3—
Capital Expenditures——-4.6-5.6—
Free Cash Flow19.949.827.358.758.7
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Kriti Nutrients financials and key ratios

Prices at the previous close · figures from the company's filings with NSE

Kriti Nutrients (NSE: KRITINUT) had a market capitalisation of ₹321 crore at the previous close (₹64.02 a share), a PE ratio of 9.6 on the last four quarters' profit and a price-to-book ratio of 1.40. In FY26 its consolidated net profit was ₹33.9 crore on revenue of ₹922 crore; in Q1 FY27 (April–June 2026) it was ₹8.9 crore, down 6.0% year on year. Its debt-to-equity ratio was 0.03 on 31 March 2026. Promoters held 66.68% of the shares on 30 September 2026.

Share price used
₹64.02 · previous close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Kriti Nutrients at a glance · consolidated

Market cap
₹321 Crat ₹64.02 · previous close
PE ratio (last 4 quarters)
9.69.5 on FY26 profit
Price to book (PB)
1.40book value ₹45.73 a share
ROE (FY26)
15.4%ROCE 16.6%
Debt to equity
0.03net cash ₹54.7 Cr
Promoter holding
66.68%unchanged vs 30 Jun 202630 September 2026
Dividend yield
4.69%₹3 a share in 12 months
Net worth
₹229 Cr+8.1% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹58.7 Cr+114.8% vs FY25

Questions

What is the Kriti Nutrients PE ratio today?

Kriti Nutrients' PE ratio is 9.6 at the previous close (₹64.02 a share): a market capitalisation of ₹321 crore divided by consolidated net profit of ₹33.3 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹33.9 crore) it is 9.5.

What is the Kriti Nutrients debt to equity ratio?

Kriti Nutrients' debt-to-equity ratio was 0.03 on 31 March 2026: borrowings of ₹7.6 crore against total equity of ₹229 crore. A year earlier, on 31 March 2025, it was 0.01.

What is the Kriti Nutrients net worth?

Kriti Nutrients' net worth — shareholders' equity in its consolidated balance sheet — was ₹229 crore on 31 March 2026, up 8.1% from ₹212 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹321 crore at the previous close.

What is the Kriti Nutrients PB ratio (price to book value)?

Kriti Nutrients' price-to-book (PB) ratio is 1.40 at the previous close: a market capitalisation of ₹321 crore divided by shareholders' equity (book value) of ₹229 crore on 31 March 2026. That is a book value of ₹45.73 per share against a share price of ₹64.02.

What is the Kriti Nutrients ROE and ROCE?

In FY26, Kriti Nutrients' return on equity (ROE) was 15.4% and its return on capital employed (ROCE) was 16.6%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).

What is the Kriti Nutrients book value per share?

Kriti Nutrients' book value per share was ₹45.73 on 31 March 2026: shareholders' equity of ₹229 crore divided by the 5.01 crore shares in issue, up 8.1% from ₹42.28 a year earlier. The share price at the previous close was ₹64.02.

What is the Kriti Nutrients market cap?

Kriti Nutrients' market capitalisation was ₹321 crore at the previous close: 5.01 crore shares at ₹64.02 each.

Is Kriti Nutrients debt free?

No. Kriti Nutrients had borrowings of ₹7.6 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.03. Its cash and current investments were ₹62.2 crore, so it held net cash of ₹54.7 crore.

What is the Kriti Nutrients EPS?

Kriti Nutrients' basic earnings per share (EPS) were ₹6.77 in FY26, against ₹7.38 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹6.66.

What is the Kriti Nutrients dividend yield?

Kriti Nutrients' dividend yield is 4.69% at the previous close: dividends of ₹3 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹64.02. They were ₹3 on 13 November 2025 (special).

What is the Kriti Nutrients free cash flow?

In FY26, Kriti Nutrients generated ₹64.3 crore of cash from operations and spent ₹5.6 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹58.7 crore. In FY25 it was ₹27.3 crore.

What is the Kriti Nutrients revenue and profit in FY26?

In FY26 (April 2025–March 2026), Kriti Nutrients' consolidated net profit was ₹33.9 crore, down 8.4% from ₹37 crore in FY25, on revenue from operations of ₹922 crore (up 25.5%).

What is the Kriti Nutrients promoter holding?

Promoters held 66.68% of Kriti Nutrients on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

What is the Kriti Nutrients shareholding pattern?

On 30 September 2026, Kriti Nutrients' shares were held by promoters 66.68%, domestic institutions (DII) 0.03% and retail and other non-institutional investors 33.29%. Over the year, DII holding was up 0.03 percentage points from 0.00%.

When are the Kriti Nutrients next results?

Kriti Nutrients has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.

What are the Kriti Nutrients latest quarterly results?

Kriti Nutrients' latest results are for Q1 FY27 (April–June 2026), filed on 11 August 2026: consolidated net profit ₹8.9 crore, down 6.0% from ₹9.5 crore in Q1 FY26; revenue from operations ₹247 crore, up 7.9% year on year.

How does Kriti Nutrients compare with its peers?

On FY26 consolidated figures, against Gokul Refoils and Solvent, Halder Venture and M K Proteins: Kriti Nutrients' operating margin of 4.1% is the highest of the four (Gokul Refoils and Solvent 0.6%, Halder Venture 3.4%, M K Proteins 2.9%; peer average 2.3%); its return on equity of 15.4% is the second highest of the four (Gokul Refoils and Solvent 5.2%, Halder Venture 16.1%, M K Proteins 9.4%; peer average 10.2%).

Kriti Nutrients vs Gokul Refoils and Solvent: how do they compare?

In FY26, Kriti Nutrients earned net profit of ₹33.9 crore on revenue of ₹922 crore, against ₹18.5 crore on ₹4,120 crore for Gokul Refoils and Solvent. Kriti Nutrients' operating margin was 4.1% (Gokul Refoils and Solvent 0.6%) and its return on equity 15.4% (Gokul Refoils and Solvent 5.2%).

Where do these Kriti Nutrients figures come from?

From Kriti Nutrients' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.